Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion type Assertion NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_head.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion description "[The large effects observed for DRD2/ANKK1 might be related to our study design, in which individual therapy was decided by the physician. Further studies are needed to clarify the genetic effects of DRD2/ANKK1 especially in eal-life settings outside clin]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_provenance.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion evidence source_evidence_literature NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_provenance.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion SIO_000772 20350135 NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_provenance.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion wasDerivedFrom gad-20150221 NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_provenance.
- NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_assertion wasGeneratedBy ECO_0000203 NP110061.RA45PINuGIP0Kgx1xsU4h3-xeIrYrjD_na15ENAIrGVk0130_provenance.